{"schema_version":"secwatch.filing_event.v1","accession":"0001295947-21-000036","form_type":"8-K","ticker":"PBH","cik":"0001295947","company_name":"Prestige Consumer Healthcare Inc.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.936585+00:00","generated_at":"2026-06-28T12:40:34.195296+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Prestige Q2 fiscal 2022 revenue record $276.2M; raises full-year guidance","bullets":["Record Q2 revenue $276.2M (+16.3% YoY); organic growth 10.5% ex-Akorn and FX.","Adjusted diluted EPS $1.02, up 30.8% YoY; GAAP diluted EPS $0.89.","Raising FY2022 outlook: revenue $1.05-$1.06B (prior $1.045B+); adj. EPS $3.93-$3.98 (prior $3.90+).","North American OTC segment $251.7M (+16.2%); International OTC $24.5M (+17.5%).","Adjusted free cash flow $61.9M in Q2; net debt ~$1.6B with leverage 4.1x."],"urls":{"canonical":"https://secwatch.observer/filing/0001295947-21-000036","json":"https://secwatch.observer/filing/0001295947-21-000036.json","markdown":"https://secwatch.observer/filing/0001295947-21-000036.md","text":"https://secwatch.observer/filing/0001295947-21-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1295947/000129594721000036/0001295947-21-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1295947/000129594721000036/pbh-20211104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:40:34.195296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}